InFo Hämatologie + Onkologie最新文献

筛选
英文 中文
Interdisziplinäre Behandlungsstrategien bei Hirnmetastasen* 脑转移瘤的跨学科治疗策略*
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0576-3
Pia Zeiner, C. Rödel, M. Czabanka, J. Steinbach
{"title":"Interdisziplinäre Behandlungsstrategien bei Hirnmetastasen*","authors":"Pia Zeiner, C. Rödel, M. Czabanka, J. Steinbach","doi":"10.1007/s15004-024-0576-3","DOIUrl":"https://doi.org/10.1007/s15004-024-0576-3","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"42 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141037034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
10 Tage Decitabin statt 3+7-Induktion 10天的地西他滨治疗,而不是3+7天的诱导治疗
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0569-2
T. Müller
{"title":"10 Tage Decitabin statt 3+7-Induktion","authors":"T. Müller","doi":"10.1007/s15004-024-0569-2","DOIUrl":"https://doi.org/10.1007/s15004-024-0569-2","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"16 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141037702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ixazomib reduziert Risiko einer chronischen GvHD 伊沙佐米可降低慢性肝纤维化的风险
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0596-z
Miriam Sonnet
{"title":"Ixazomib reduziert Risiko einer chronischen GvHD","authors":"Miriam Sonnet","doi":"10.1007/s15004-024-0596-z","DOIUrl":"https://doi.org/10.1007/s15004-024-0596-z","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"50 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141033179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thromboserisiko oft monatelang erhöht 经常监测血栓形成情况
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0570-9
E. Oberhofer
{"title":"Thromboserisiko oft monatelang erhöht","authors":"E. Oberhofer","doi":"10.1007/s15004-024-0570-9","DOIUrl":"https://doi.org/10.1007/s15004-024-0570-9","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"26 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141035789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Das Herzrisiko dürfte sinken 心脏风险应降低
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0577-2
E. Oberhofer
{"title":"Das Herzrisiko dürfte sinken","authors":"E. Oberhofer","doi":"10.1007/s15004-024-0577-2","DOIUrl":"https://doi.org/10.1007/s15004-024-0577-2","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"111 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141050525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guter Outcome auch beim Urothelkarzinom 对尿路上皮癌也有良好疗效
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0584-3
Miriam Sonnet
{"title":"Guter Outcome auch beim Urothelkarzinom","authors":"Miriam Sonnet","doi":"10.1007/s15004-024-0584-3","DOIUrl":"https://doi.org/10.1007/s15004-024-0584-3","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"49 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141039031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mehr internistisch-onkologisches Wissen für alle: Neue App „medbee“ erleichtert Praxisalltag 为每个人提供更多内部肿瘤知识:新版 "medbee "应用程序让日常工作更轻松
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0601-6
Redaktion Facharztmagazine
{"title":"Mehr internistisch-onkologisches Wissen für alle: Neue App „medbee“ erleichtert Praxisalltag","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15004-024-0601-6","DOIUrl":"https://doi.org/10.1007/s15004-024-0601-6","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"17 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141053439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MONARCH-3-Studie: Vorteil im Hinblick auf das Gesamtüberleben mit Abemaciclib MONARCH-3研究:abemaciclib可提高总生存率
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0585-2
Silke Wedekind
{"title":"MONARCH-3-Studie: Vorteil im Hinblick auf das Gesamtüberleben mit Abemaciclib","authors":"Silke Wedekind","doi":"10.1007/s15004-024-0585-2","DOIUrl":"https://doi.org/10.1007/s15004-024-0585-2","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"9 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141035989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kombinationen aus Chemotherapie, Immuntherapie und PARP-Inhibition 化疗、免疫疗法和 PARP 抑制剂的联合应用
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0574-5
Michael Eichbaum, Christine Eichbaum
{"title":"Kombinationen aus Chemotherapie, Immuntherapie und PARP-Inhibition","authors":"Michael Eichbaum, Christine Eichbaum","doi":"10.1007/s15004-024-0574-5","DOIUrl":"https://doi.org/10.1007/s15004-024-0574-5","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"18 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141043931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beim Melanom wenig erfolgreich? 黑色素瘤治疗效果不佳?
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0599-9
T. Müller
{"title":"Beim Melanom wenig erfolgreich?","authors":"T. Müller","doi":"10.1007/s15004-024-0599-9","DOIUrl":"https://doi.org/10.1007/s15004-024-0599-9","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"4 7-8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141023691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信